Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-20

Clinical Trial Update: An Observational Study to Collect Data on How Aflibercept (Eylea) Given Using a Paediatric Dosing Device is Used in Preterm Babies With Retinopathy of Prematurity in the United Kingdom (UK)

View source ↗

Summary

An observational UK study collecting data on how aflibercept (Eylea) is used in preterm infants with retinopathy of prematurity, using a paediatric dosing devic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EYLEA (Aflibercept)

Snippet

Sponsor: Bayer | Conditions: Retinopathy of Prematurity, Preterm Infants | Status: RECRUITING